These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14601033)

  • 1. Pharmacogenetics and mood stabilization in bipolar disorder.
    Ruzickova M; Turecki G; Alda M
    Am J Med Genet C Semin Med Genet; 2003 Nov; 123C(1):18-25. PubMed ID: 14601033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder.
    Alda M; Grof P; Rouleau GA; Turecki G; Young LT
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1038-45. PubMed ID: 15946781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of lithium response in bipolar disorder.
    Alda M
    J Psychiatry Neurosci; 1999 Mar; 24(2):154-8. PubMed ID: 10212559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder.
    McQuillin A; Rizig M; Gurling HM
    Pharmacogenet Genomics; 2007 Aug; 17(8):605-17. PubMed ID: 17622937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics and bipolar disorder.
    Mamdani F; Groisman IJ; Alda M; Turecki G
    Pharmacogenomics J; 2004; 4(3):161-70. PubMed ID: 15079146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phenotypic spectra of bipolar disorder.
    Alda M
    Eur Neuropsychopharmacol; 2004 May; 14 Suppl 2():S94-9. PubMed ID: 15142614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel technique to evaluate fluctuations of mood: implications for evaluating course and treatment effects in bipolar/affective disorders.
    Sree Hari Rao V; Raghvendra Rao C; Yeragani VK
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):453-66. PubMed ID: 17042883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment-refractory bipolar disorder: classification to aid in clinical management.
    Gajwani P
    Expert Opin Pharmacother; 2009 Aug; 10(12):1907-15. PubMed ID: 19606936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sexual dysfunctions and bipolar disorder: a study of patients submitted to a long- term lithium treatment].
    Zuncheddu C; Carpiniello B
    Clin Ter; 2006; 157(5):419-24. PubMed ID: 17147049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium response across generations.
    Grof P; Duffy A; Alda M; Hajek T
    Acta Psychiatr Scand; 2009 Nov; 120(5):378-85. PubMed ID: 19807719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of lithium in modulation of brain genes: relevance for aetiology and treatment of bipolar disorder.
    Fatemi SH; Reutiman TJ; Folsom TD
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1090-5. PubMed ID: 19754458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.
    Lan MJ; McLoughlin GA; Griffin JL; Tsang TM; Huang JT; Yuan P; Manji H; Holmes E; Bahn S
    Mol Psychiatry; 2009 Mar; 14(3):269-79. PubMed ID: 18256615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood stabilization in the treatment of bipolar disorder: focus on quetiapine.
    Vieta E
    Hum Psychopharmacol; 2005 Jun; 20(4):225-36. PubMed ID: 15880391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.
    Gould TD; Quiroz JA; Singh J; Zarate CA; Manji HK
    Mol Psychiatry; 2004 Aug; 9(8):734-55. PubMed ID: 15136794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium specificity in bipolar illness: a classic agent for the classic disorder.
    Gershon S; Chengappa KN; Malhi GS
    Bipolar Disord; 2009 Jun; 11 Suppl 2():34-44. PubMed ID: 19538684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes.
    Padmos RC; Hillegers MH; Knijff EM; Vonk R; Bouvy A; Staal FJ; de Ridder D; Kupka RW; Nolen WA; Drexhage HA
    Arch Gen Psychiatry; 2008 Apr; 65(4):395-407. PubMed ID: 18391128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mood-stabilizing drugs: are their neuroprotective aspects clinically relevant?
    Lagace DC; Eisch AJ
    Psychiatr Clin North Am; 2005 Jun; 28(2):399-414. PubMed ID: 15826739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of bipolar disorder: new perspectives.
    Alda M; Hajek T; Calkin C; O'Donovan C
    Ann Med; 2009; 41(3):186-96. PubMed ID: 18821183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.